Genova Clinical Research: Current Studies

Diabetes

Genova Clinical Research is conducting a research study to evaluate the safety and effectiveness of an investigational medication for individuals with Type 2 diabetes who are not being treated with insulin.

There are up to 14 visits over up to 18 months. Qualified participants will receive study medications, study related physicals, and lab work at no charge. Compensation may be available to qualified participants for each completed visit for time and travel expenses.

If you are interested in this study you should:

Be 18 years of age or older
Have uncontrolled type 2 diabetes
Not be on insulin
Be on at least 2 oral diabetic medications (combination drugs count as 2)
Have had type 2 diabetes for at least one year
Have not had cancer within the last 5 years (except for successfully treated basal or squamous cell)

If you are interested in finding out more about this study, please call us at 520-575-2834. One of our staff will be happy to give you further information regarding this study and will schedule an appointment to allow you to discuss the study in more detail with one of our physicians. We appreciate your interest in this study and look forward to making your research experience a pleasant one. Feel free to pass this information along to anyone you think may be interested.

Diabetes

Genova Clinical Research is conducting a research study to evaluate the safety and tolerability of an investigational medication vs. a placebo for subjects with type 2 diabetes treated with metformin.

There are 10 visits over approximately 10 weeks. Qualified participants will receive study medications, study related physicals, and lab work at no charge. Compensation may be available to qualified participants for each completed visit for time and travel expenses.

If you are interested in this study you should:

Be between the ages of 18 and 65
Have type 2 diabetes that is being treated with metformin alone
Have not had cancer within the last 5 years (except for successfully treated basal or squamous cell or treated in situ cervical cancer)

Diabetes

This is a clinical research study testing the safety and effectiveness of an investigational medication at two different doses versus a placebo (a dummy tablet designed to look like the investigational medication) for patients with Type 2 Diabetes who have blood glucose levels higher than normal despite diet and exercise and receiving multiple daily injections of insulin alone or with metformin. There are 16 visits over approximately 52 weeks. Qualified participants will receive study drug, study related physicals and study related lab work at no charge. Compensation for time and travel is also available for qualified participants for each completed visit.

Participants must:

Be 18 years of age or older
Have type 2 diabetes
Currently taking insulin alone or with metformin
Have insufficient blood sugar control despite diet, exercise and multiple daily injections of insulin
Not have had any cancer within the last 5 years (basal cell carcinoma is ok)

If you are interested in finding out more about this study please call us at 520-575-2834. One of our staff will be happy to give you further information about the study and can make an appointment for you to discuss the study further with one of our study physicians. Thank you in advance for your consideration in participating in this research study.

Diabetes with Heart Disease

Genova Clinical Research, Inc. is conducting a clinical research study of an investigational drug vs. a comparator drug for individuals with diabetes with an established cardiovascular disease, or with diabetes and at risk of cardiovascular disease.

This is a clinical research study evaluating the long term cardiovascular outcome of subjects with Type 2 Diabetes who are at risk for cardiovascular disease using an investigational medication and an approved medication. There are up to 32 visits over approximately 400 weeks. Qualified participants will receive study drug, study related physicals and lab work at no charge. Qualified subjects may be reimbursed for costs associated with study visits, such as travel expenses, for each completed visit.

Participants must:

Be between the ages of 40 and 85 inclusive
Have type 2 diabetes
Have an established cardiovascular disease (such as known coronary artery disease, heart attack, or stroke), or have one of the following risk factors: moderately impaired kidney function, 70 years of age or more, type 2 diabetes for more than 10 years, high blood pressure, currently smoking or high levels of low-density lipoprotein cholesterol (LDL)
Not have had any cancer within the last 3 years (treated non-melanoma skin cancer is ok)

Diabetes

Genova Clinical Research, Inc. is conducting a clinical research study of an investigational drug vs. placebo (an inactive substance) for the treatment of patients with diabetes with an established cardiovascular disease, or with diabetes and is at risk of cardiovascular disease.

This study lasts approximately 60 months and includes 11 office visits. Qualified participants will receive study medications, study related physicals, and lab work at no charge. Compensation may be available to qualified participants for each completed visit for time and travel expenses.

If you are interested in this study you should:

Be 40 years or older
Have type 2 diabetes
Have an established cardiovascular disease (such as known coronary artery disease, heart attack, or stroke), or have one of the following risk factors: uncontrolled blood pressure, currently smoking, high levels of low-density lipoprotein cholesterol (LDL), or low levels of high-density lipoprotein cholesterol (HDL)
Not currently have cancer

Become a volunteer: Genova Clinical Research is enrolling patients for new research studies. If you are interested in participating please contact us.